Diabetes Care Standards 2024: Evidence-Based Guidelines for Management

A comprehensive set of evidence-based guidelines encompassing the management of type 1 diabetes, type 2 diabetes, gestational diabetes, and prediabetes is introduced for effective diabetes care.

January 2024
Diabetes Care Standards 2024: Evidence-Based Guidelines for Management

Diabetes Care Standards 2024: Evidence-Based Guide

American Diabetes Association publishes 2024 Diabetes Care Standards

The new guidelines include updates to recommendations on a new class of obesity medications, new screening practices, diabetes technology, and the use of teplizumab. 

The American Diabetes Association® (ADA) published the  Diabetes Standards of Care —2024 , a set of comprehensive, evidence-based guidelines for the management of type 1, type 2, gestational diabetes, and prediabetes, based on the latest research. scientific and clinical trials. Includes strategies to diagnose and treat diabetes in both youth and adults, methods to prevent or delay type 2 diabetes and its comorbidities, such as cardiovascular disease (CVD) and obesity, and therapeutic approaches to minimize complications and improve outcomes. of health. 

"The latest ADA guidelines present critical updates for healthcare professionals, ensuring comprehensive, evidence-based care for diabetes management. These changes reflect our ongoing commitment to optimizing patient outcomes through best practices. informed, adaptive, and patient-centered health care policies," said Robert Gabbay, MD, PhD, chief scientific and medical officer of the ADA. "The  ADA Standards of Care  ensure that health care professionals, especially our primary care workforce, provide the best possible care to those living with diabetes." 

Notable updates to the  Diabetes Standards of Care─2024  include: 

  • New updates in the management of obesity in people with diabetes, including approaches to reduce therapeutic inertia, support greater personalization, and incorporate additional obesity measures beyond body mass index (i.e., waist circumference, waist-to-waist ratio). hip and height). 
     
  • New recommendations for screening for heart failure in people with diabetes. 
     
  • Updated recommendations for the detection of peripheral arterial disease (PAD) in people with diabetes. 
     
  • Guidance on screening and use of teplizumab, approved to delay the onset of type 1 diabetes. 
     
  • More guidance on the use of new obesity medications, glucagon-like peptide-1 (GLP-1) agonists or glucose-dependent insulinotropic polypeptide (GIP) receptor dual agonists, to achieve sustained weight control goals. 
     
  • Updates to guidance on the diagnosis and classification of diabetes. 
     
  • A focus on the prevention and treatment of hypoglycemia. 
     
  • Emphasis on screening for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis in people with diabetes in primary care and diabetes clinics. 
     
  • New emphasis on assessment and treatment of bone health and increased attention to diabetes-specific fracture risk factors. 
     
  • A focus on the detection and treatment of people with diabetes and disabilities. 
     
  • Emphasis on enabling healthcare providers to master diabetes technology, using artificial intelligence for retinal screening with necessary referrals and adopting digital and telehealth tools for diabetes self-management education. 
     
  • New information on the possible association between COVID-19 infections and the onset of type 1 diabetes. 

 


"As chair of the ADA’s professional practice committee, I am pleased to share our recent updates to advance diabetes care through new scientific insights and technological innovation, all aimed at improving the experience of people with diabetes and professionals. in the management of this complex condition," said Nuha A. El Sayed, MD, MM Sc, senior vice president of healthcare improvement at the ADA. 

Other notable changes to the  2024 Standards of Care  include: 

  • Vaccination guidance updated to include newly approved RSV vaccines in adults over 60 years of age with diabetes. 
     
  • New emphasis on cultural sensitivity in diabetes self-management education, with considerations for changing reimbursement policies. 
     
  • More details and emphasis on psychosocial screening protocols to better identify diabetes distress. 
     
  • The importance of technology for diabetes, with an emphasis on continuous glucose monitors (CGM) and automated insulin delivery (AID) systems. 
     
  • Continued emphasis on inclusion and person-centered care. 

“At the ADA, we are focused on improving the quality of care for anyone living with diabetes, prediabetes, or at risk of developing diabetes. Standards  of Care  are critical to ensuring better treatment of diabetes, a chronic disease that requires ongoing care through a well-informed and coordinated healthcare team. These standards equip healthcare professionals with the gold standard in diabetes care, ensuring the highest level of service and knowledge in the field,” said Chuck Henderson, executive director of the ADA. 

The ADA annually updates its  Standards of Care  through the efforts of its Professional Practice Committee (PPC). The PPC, composed of 21 global experts from diverse professional backgrounds, includes physicians, nurses, certified diabetes education and care specialists, registered dietitians, pharmacists and methodologists. Its members have experience in areas such as pediatric and adult endocrinology, epidemiology, public health, cardiovascular risk management, kidney diseases, microvascular complications, preconception and pregnancy care, weight control, diabetes prevention, mental health and behavioral, hospital care and technology in diabetes. In addition, the committee collaborates with 19 experts on specialized content.

The  2024 Standards of Care  have earned endorsements from the American College of Cardiology (Section 10), the American Society for Bone and Mineral Research (Bones section in Section 4), and the Obesity Society (Section 8). 

Today, the  Diabetes Standards of Care—2024  are available online and published as a companion to the January 2024 edition of  Diabetes Care® . An abbreviated version of the guidelines, known as the  Abbreviated Standards of Care  , will be available to primary care providers in the journal Clinical Diabetes®, along with a convenient  Standards of Care app   and a pocket-sized  Standards of Care chart .

The online version will receive real-time annotations with necessary updates if new evidence or regulatory changes warrant immediate incorporation through the   “live” Standards of Care process. Other resources on standards of care, including a webcast with continuing education (CE) credits and a complete slide presentation, can be found on the ADA’s professional website,  DiabetesPro® .